AVEO Oncology, an LG Chem company ("AVEO"), is a biopharmaceutical company that is trying to provide differentiated solutions to improve cancer patients lives, presented two posters during the 2025 ...

A wellness retreat embracing nature and modern science Set against the stunning backdrop of the Sahyadri mountains, Swastik ...

A major milestone and a new look for Newberry County Friday evening.The hospital, previously known as Newberry Health, is ...

Members of Philadelphia’s queer community share the films and TV series that make them swoon, from "Moonlight" to "The L Word ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaRegenerative Medicine ...

Full Year and Q4 Group performance highlightsSales of EUR 18.0 billion in 2024, comparable sales growth 1%; EUR 5.0 billion in ...

Market was valued at USD 1564 Million in 2023 and is anticipated to reach USD 5374 Million by 2030, witnessing a CAGR of 16.9% during the forecast period 2024-2030.

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

Nonprofit organizations across the country were plunged into uncertainty after the White House froze spending on federal ...